Concurrent chemo-endocrine treatment for early hormone-positive breast cancer: a no-go???
Crossref DOI link: https://doi.org/10.1007/s10549-021-06505-z
Published Online: 2022-02-07
Published Print: 2022-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jacobs, C. F. http://orcid.org/0000-0002-7294-4364
Soesan, M.
Sonke, G. S.
Text and Data Mining valid from 2022-02-07
Version of Record valid from 2022-02-07
Article History
Received: 6 October 2021
Accepted: 29 December 2021
First Online: 7 February 2022
Declarations
:
: The authors have declared no conflict of interest related to this work.